About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,342 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,342 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 821-840 of 3,342 trials

TerminatedA Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced MelanomaThe purpose of this study is to learn about the effects of 3 study medicines (encorafenib, binimetinib, pembrolizumab) compared to 2 study medicines (ipilimumab and nivolumab)…NCT05926960·Tübingen, Baden-Wurttemberg and 23 others

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

TerminatedHypofractionated Radiotherapy for Nonmelanoma Skin CancerRadiotherapy is a treatment considered standard for non melanoma skin cancer. This institution uses schemes of 4 to 6 weeks of treatment.NCT02080962·Barretos, São Paulo

TerminatedRPTR-147 in Patients With Selected Solid Tumors and LymphomasThe purpose of this study is to assess the safety and tolerability of escalating doses of RPTR-147 as a monotherapy and in combination with Pembrolizumab in patients with selected…NCT03815682·Duarte, California and 6 others

Active not recruitingMinimal SN Tumor BurdenThe purpose of this registry is to collect data in order to discover whether melanoma patients with minimal SN tumor burden should undergo a complete lymph node dissection (CLND)…NCT01942603·Leuven and 21 others

CompletedEvaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk MelanomaThis study will evaluate the immunization effects of a vaccine for patients who are at risk for recurrence of their skin cancer.NCT00273910·Bethesda, Maryland

RecruitingPilot Study of Bone Mineral Density Changes During Anti-PD-1 ImmunotherapyImmune checkpoint inhibitors (ICIs) have revolutionized cancer treatment and work by blocking protein interactions that normally prevent the immune system from recognizing and…NCT07555210·Nashville, Tennessee

Not yet recruitingClinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma PatientsRheumatologic adverse events are expected to affect between 3% and 7.5% of patients undergoing immunotherapy and are likely to be underdiagnosed.NCT06780397·Rome, Lazio

Completedflt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell CancerRATIONALE: The drug flt3L may stimulate a person's immune system and help to kill tumor cells.NCT00019396·Bethesda, Maryland

TerminatedUse of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic MelanomaBackground: \- Researchers have developed an experimental cancer treatment called cell therapy.NCT01369888·Bethesda, Maryland

TerminatedStudy of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1This is a Phase 1/2, open label, multi-centre study to assess the safety, tolerability, PD, and efficacy of adjuvant immunotherapy EVX-02 vaccine and anti-PD-1 (Nivolumab) in…NCT04455503·Goulburn, New South Wales and 5 others

CompletedT-VEC in Non-melanoma Skin CancerEvaluation of the mechanism of Action of talimogene laherparepvec (T-VEC) in patients with locally advanced non-melanoma skin cancer.NCT03458117·Zurich

TerminatedImvamune Vaccine for the Treatment of Non-melanoma Skin CancerThis study examines the safety and efficacy of using the Imvamune smallpox vaccine in the treatment of non-melanoma skin cancers (basal cell carcinoma and squamous cell carcinoma).NCT04410874·Montreal, Quebec

CompletedCabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsThis phase I trial studies the side effects and best dose of cabozantinib S-malate in treating younger patients with solid tumors that have come back or no longer respond to…NCT01709435·Birmingham, Alabama and 22 others

RecruitingBI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)The goal of this first in human clinical trial is to test BI-1808 administered as single agent and in combination with pembrolizumab in subjects with advanced malignancies whose…NCT04752826·Duarte, California and 24 others

UnknownRelative Bioavailability of Binimetinib 3 x 15 mg and 45 mg FormulationsThe current commercially available MEKTOVI® (binimetinib) 15 mg tablets are provided as immediate release film-coated tablets for oral administration.NCT05103891·Rennes

Enrolling by invitationNatural History Study of Early Life Exposures in Agriculture (ELEA)Study Description: ELEA is an observational cohort study that will collect exposure information and biospecimens from the adult children of the Agricultural Health Study (AHS)…NCT07328516·Bethesda, Maryland

RecruitingStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.This is a Phase 3, multicenter, open-label, randomized, parallel group, treatment study to assess the efficacy and safety of lifileucel in combination with pembrolizumab compared…NCT05727904·Birmingham, Alabama and 81 others

TerminatedIpilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin DiftitoxThis is an open-label, clinical efficacy study of Ipilimumab in patients with Stage IIIC and Stage IV melanoma who have recently been treated with Denileukin Diftitox.NCT02009384·Louisville, Kentucky

CompletedEfficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)The aim of this observational study is to document the efficacy and tolerability of high-dose interferon therapy in adult participants with malignant melanoma at high risk of…NCT00749684

Not yet recruitingEvaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk MelanomaThis research study is testing a decision aid to help patients think through whether to have sentinel lymph node biopsy for melanoma.NCT07653087·Charlottesville, Virginia

PreviousPage 42 of 168Next